Abstract
Background While ultrasound guided fine needle aspiration (US-FNA) is commonly used to biopsy suspicious thyroid nodules, its use is associated with a high rate of nondiagnostic and indeterminate samples. The objective of this study was to compare the diagnostic performance of a new motorized FNA device (CytoCore®, Praxis Medical) to a historical cohort of patients biopsied using US-FNA within the same health system and literature controls.
Materials and Methods Data from 120 patients with suspicious thyroid nodules undergoing thyroid biopsy with a motorized FNA device between March 2022 and August 2023 was retrospectively analyzed. Patient demographics, lesion characteristics, number of passes required, Bethesda category, and cellularity scores were compared to a historical control cohort of 100 patients who underwent US-FNA between March 2019 and March 2020. All patients underwent the procedure within the same health system. Nondiagnostic and indeterminate samples rates for the motorized FNA device were separately compared to literature controls.
Results A significantly reduced median number of passes were required with the motorized FNA device compared to US-FNA (z = 8.235, p < .001). Adequate samples were obtained after the first pass for 58% of nodules biopsied with motorized FNA device compared to only 11% with US-FNA. The cumulative percentage of adequate samples increased to 98% after two passes for the motorized FNA group versus only 58% for the US-FNA group. Eleven percent of subjects in the US-FNA required 5 passes to obtain an adequate sample. The mean cellularity score was also greater for the motorized FNA group (3.5 ± 0.5 vs. 2.0 ± 0.6; z = 5.201, p < .001). Compared to published rates, the motorized had a lower nondiagnostic rate (2.0% vs. 10% to 15%) and lower indeterminate rate (8.3% vs. 20%; p=0.05) compared to the use of FNA.
Conclusion The motorized FNA device requires less passes to obtain an adequate biopsy than US-FNA, thus decreasing procedure length, tissue trauma, and damage to the specimen damage. Its use is also associated with obtaining samples with a higher cellularity and lower nondiagnostic and indeterminate sample rates.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol for this retrospective study received approval under Expedited Review with waiver of consent by the BayCare Health System Institutional Review Board (FWA 00006065 IORG 0003355).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Declaration of Conflicting of Interest None
Funding Funding for this study, including data collection, statistical analysis and medical writing, was provided by Praxis Medical, LLC, Tampa, Florida.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
